eli lilly covid antibody drug cost based on nation's wealth, says ceo
Published 3 years ago • 3K plays • Length 6:52Download video MP4
Download video MP3
Similar videos
-
6:52
eli lilly antibody drug will reduce hospitalizations: ceo
-
4:09
lilly pulls ahead of novo in obesity drug race
-
5:56
eli lilly ceo says science will win in covid fight
-
2:36
eli lilly covid antibody drug gets emergency fda clearance
-
7:43
lilly aims to produce 100k covid-19 antibody doses by year end: cfo
-
11:48
antibody therapy for covid - bamlanivimab (eli lilly’s monoclonal antibody)
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results
-
9:34
doctor on eli lilly's antibody treatment and child stress amid covid-19
-
23:50
eli lilly ceo says virus will be 'endemic'
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
1:41
eli lilly ceo explains supply chain of covid-19 antibody drug
-
3:51
eli lilly has priced its antibody drug based on a country’s gross national income
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
19:58
facing forward: eli lilly ceo david ricks on covid-19 treatments
-
5:32
lilly tests covid-19 antibody drug in nursing home facilities
-
2:38
eli lilly ceo on drug that could aid covid-19 recovery when paired with remdesivir
-
6:13
eli lilly ceo urges hospitals to administer unused antibody treatments
-
25:10
david ricks, chairman and ceo, eli lilly and company